Incyte (INCY) EBIT (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.34% |
| Dec 31, 2025 | -24.27% |
| Sep 30, 2025 | -16.37% |
| Jun 30, 2025 | 158.48% |
| Mar 31, 2025 | -31.95% |
| Dec 31, 2024 | 106.40% |
| Sep 30, 2024 | 130.55% |
| Jun 30, 2024 | -620.28% |
| Mar 31, 2024 | -50.93% |
| Dec 31, 2023 | -12.78% |
| Sep 30, 2023 | 10.80% |
| Jun 30, 2023 | 682.32% |
| Mar 31, 2023 | -64.66% |
| Dec 31, 2022 | -49.35% |
| Sep 30, 2022 | -45.61% |
| Jun 30, 2022 | 118.32% |
| Mar 31, 2022 | 5.24% |
| Dec 31, 2021 | -52.96% |
| Sep 30, 2021 | 67.15% |
| Jun 30, 2021 | 42.55% |
| Mar 31, 2021 | -39.84% |
| Dec 31, 2020 | 2,983.53% |
| Sep 30, 2020 | -97.69% |
| Jun 30, 2020 | 134.75% |
| Mar 31, 2020 | -798.89% |
| Dec 31, 2019 | -29.27% |
| Sep 30, 2019 | 36.21% |
| Jun 30, 2019 | 33.13% |
| Mar 31, 2019 | 421.69% |
| Dec 31, 2018 | -173.99% |
| Sep 30, 2018 | -62.61% |
| Jun 30, 2018 | 224.03% |
| Mar 31, 2018 | -4,125.79% |
| Dec 31, 2017 | -88.90% |
| Sep 30, 2017 | 106.90% |
| Jun 30, 2017 | 105.45% |
| Mar 31, 2017 | -103.97% |
| Dec 31, 2016 | -393.06% |
| Sep 30, 2016 | -50.01% |
| Jun 30, 2016 | 23.72% |
| Mar 31, 2016 | 111.10% |
| Dec 31, 2015 | 17,002.97% |
| Sep 30, 2015 | 98.63% |
| Jun 30, 2015 | -6.62% |
| Mar 31, 2015 | 72.94% |
| Dec 31, 2014 | -136.64% |
| Sep 30, 2014 | 367.09% |
| Jun 30, 2014 | -14.18% |
| Mar 31, 2014 | 21.01% |
| Dec 31, 2013 | -120.25% |
| Sep 30, 2013 | -176.12% |
| Jun 30, 2013 | 522.72% |
| Mar 31, 2013 | -130.00% |
| Dec 31, 2012 | 234.69% |
| Sep 30, 2012 | -166.61% |
| Jun 30, 2012 | 144.52% |
| Mar 31, 2012 | 22.54% |
| Dec 31, 2011 | -4.83% |
| Sep 30, 2011 | -2.41% |
| Jun 30, 2011 | -159.80% |
| Mar 31, 2011 | -192.46% |
| Dec 31, 2010 | 177.60% |
| Sep 30, 2010 | -261.89% |
| Jun 30, 2010 | 168.70% |